Winners announced in second round of theKidneyX COVID-19 Kidney Care Challenge

ASN and HHS are funding innovators who will transform kidney care
American Society of Nephrology (ASN)

 

Newswise — Washington, DC (April 6, 2021) —Today, the American Society of Nephrology (ASN) announced seven winners in Round 2 of the KidneyX COVID-19 Kidney Care Challenge. From December to January, healthcare providers, dialysis centers, nonprofit health systems, and other entrants submitted solutions that could reduce the transmission of coronavirus among people with kidney disease and/or reduce the risk of kidney damage among people who contract the virus. 

The challenge is a joint effort of the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology. “The KidneyX COVID-19 Kidney Care Challenge received a range of resourceful solutions that could benefit patients with kidney disease and front-line health care workers,” said HHS Assistant Secretary for Health Dr. Rachel L. Levine. “As we continue to fight the COVID-19 pandemic, we are pleased to recognize these innovators and to share their work with communities across the nation.” 

Winners will receive $20,000 each to recognize their inspiring advances in data management, detection, and telehealth. 

  • CADIS (Albuquerque, NM). Mixed reality smart glasses supporting kidney disease management through telehealth and telemonitoring.
  • Jacob Stevens, M.D.; Assistant Professor of Medicine at Columbia University Irving Medical Center (New York, NY). Customized data management tools to reduce coronavirus transmission in healthcare settings and maximize the number of patients receiving renal replacement therapy.
  • NewYork-Presbyterian (New York, NY). Proactive, structured workflow to monitor and manage patients with kidney transplants during the COVID-19 pandemic.
  • Outset Medical (San Jose, CA). Cloud-based remote monitoring of the Tablo Hemodialysis System that enables clinicians to track critical treatment parameters in real-time during the COVID-19 pandemic.
  • Paraic Kenny, Ph.D.; Gundersen Medical Foundation (La Crosse, WI). Genetic sequencing of COVID-19 cases to determine patterns of spread and inform infection control practices.
  • Renal Research Institute (New York, NY). Pool testing of used masks from hemodialysis patients and clinic staff to identify SARS-CoV-2.
  • Winnie Cheng, StockMyPantry (West New York, NJ). Delivery of dietician-recommended groceries for dialysis and transplant patients in need.

“COVID-19 continues to threaten the safety of lifesaving treatment options and place Americans living with kidney disease at increased risk of severe illness,” said KidneyX Steering Committee Chair John Sedor, MD. “Through prize competitions like the COVID-19 Kidney Care Challenge, KidneyX is addressing vital needs in the treatment of kidney disease — particularly for communities facing severe health disparities.” 

The first round of the challenge, which ran from November to December, named eight winners in January 2020. KidneyX published detailed summaries of the Round 1 and Round 2 winning solutions for the public to read, share, and adapt.

 

Learn more about the COVID-19 Kidney Care Challenge at kidneyx.org.

 

About KidneyX

The Kidney Innovation Accelerator (KidneyX), a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN), is accelerating innovation in the prevention, diagnosis, and treatment of kidney diseases. KidneyX seeks to improve the lives of people with kidney disease by expediting the development of drugs, devices, biologics, and other therapies across the spectrum of kidney care. 

KidneyX has already completed three other competitions, awarding $4 million in prizes: the Patient Innovator Challenge and Redesign Dialysis Phase 1 and Phase 2. These competitions sought to improve the quality of life for people with kidney failure by improving current dialysis treatment through innovations that reduce infection risk, improve vascular access, and replace kidney functions. The $10 million Artificial Kidney Prize, a competition to accelerate artificial kidney development toward human clinical trials, accepted Phase 1 submissions through March 24, 2021.

 

For more information, visit kidneyx.org.

 

 

About the American Society of Nephrology

Since 1966, the American Society of Nephrology (ASN) has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 21,000 members representing 131 countries. For more information, visit asn-online.org.

 

 

About the U.S. Department of Health and Human Services

The U.S. Department of Health and Human Services (HHS) enhances and protects the health and well-being of all Americans. HHS fulfills that mission by providing for effective health and human services and fostering advances in medicine, public health, and social services. For more information, visit hhs.gov.

Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 20,000 members representing 131 countries. For more information, please visit www.asn-online.org or contact the society at 202-640-4660.

 

# # #

 

 



Filters close

Showing results

110 of 5835
Newswise: Pandemic-Era Crowdfunding More Common, Successful in Affluent Communities
Released: 16-Jun-2021 5:05 PM EDT
Pandemic-Era Crowdfunding More Common, Successful in Affluent Communities
University of Washington

A new University of Washington study of requests and donations to the popular crowdfunding site GoFundMe, along with Census data, shows stark inequities in where the money went and how much was donated.

Newswise: In Show of COVID-19 Vaccine Confidence, 96% of America’s Ophthalmologists Already Vaccinated
Released: 16-Jun-2021 3:50 PM EDT
In Show of COVID-19 Vaccine Confidence, 96% of America’s Ophthalmologists Already Vaccinated
American Academy of Ophthalmology (AAO)

The American Academy of Ophthalmology is calling on its members to continue to build confidence in COVID-19 vaccines and encourage people to get vaccinated, including their staff.

Newswise: Biophysical Study Sheds Light on Potentially Druggable Process of SARS-CoV-2 Replication
Released: 16-Jun-2021 12:50 PM EDT
Biophysical Study Sheds Light on Potentially Druggable Process of SARS-CoV-2 Replication
National Institute of Biomedical Imaging and Bioengineering

This study investigates how the nucleocapsid protein, or N protein, of the SARS-CoV-2 virus packages the viral genome.

Newswise: ‘Wonder material’ can be used to detect COVID-19 quickly, accurately
Released: 16-Jun-2021 11:55 AM EDT
‘Wonder material’ can be used to detect COVID-19 quickly, accurately
University of Illinois at Chicago

Researchers at the University of Illinois Chicago have successfully used graphene — one of the strongest, thinnest known materials — to detect the SARS-CoV-2 virus in laboratory experiments.

Newswise: UCLA-led Research Finds Connections Between Air Quality and COVID Vulnerability
Released: 16-Jun-2021 11:05 AM EDT
UCLA-led Research Finds Connections Between Air Quality and COVID Vulnerability
UCLA Fielding School of Public Health

Even as governments across the United States consider lifting mask mandates and relaxing preventative measures as vaccination numbers creep up, new research from a UCLA-led team has found that such basic techniques significantly reduce the risk of getting COVID-19. In addition, the research found that U.S. counties with higher exposures to poor air quality, historically, saw higher county-level COVID-19 mortality rates in 2020.

Newswise: Story Tips from Johns Hopkins Experts on COVID-19
Released: 16-Jun-2021 11:00 AM EDT
Story Tips from Johns Hopkins Experts on COVID-19
Johns Hopkins Medicine

NEWS STORIES IN THIS ISSUE: - Stressed About “Returning to Normal”? Here Are Tips to Ease Into the Transition - Be Your Brother’s Keeper: Steps for Faith-Based Communities to Reopen Safely

Newswise: Virtual Event For June 17, 11AM EDT: COVID-19 Vaccines and Male Fertility
Released: 16-Jun-2021 8:55 AM EDT
Virtual Event For June 17, 11AM EDT: COVID-19 Vaccines and Male Fertility
Newswise

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

Released: 16-Jun-2021 8:00 AM EDT
Two COVID-19 Vaccines Show Safety, Strong Immunity in Infant Model
University of North Carolina School of Medicine

The Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research. There were no adverse effects.

access_time Embargo lifts in 2 days
Embargo will expire: 17-Jun-2021 5:00 AM EDT Released to reporters: 16-Jun-2021 5:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Jun-2021 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 5835

close
1.1968